Overview
Bumetanide is a loop diuretic belonging to the sulfonamide class, first introduced in the 1970s as a more potent alternative to furosemide. It acts on the ascending limb of the loop of Henle in the kidney, inhibiting the Na-K-2Cl symporter to promote diuresis. As a high-ceiling diuretic, bumetanide is approximately 40 times more potent than furosemide on a weight basis. It is primarily used in clinical settings for managing fluid retention associated with various medical conditions, offering rapid onset of action and predictable pharmacokinetics.
Physical and Chemical Properties
Bumetanide appears as a white to off-white crystalline powder with a characteristic bitter taste. Its molecular structure contains both sulfonamide and benzoic acid functional groups, contributing to its pharmacological activity and solubility profile. The compound shows limited water solubility but dissolves well in organic solvents like ethanol and methanol. Its stability is optimal at neutral pH, with degradation occurring under strongly acidic or alkaline conditions. The melting point range of 230-233°C indicates its crystalline purity.
Main Applications
In clinical medicine, bumetanide is primarily prescribed for treating edema associated with congestive heart failure, hepatic cirrhosis, and renal disease. Its rapid diuretic effect makes it valuable in acute care settings where prompt fluid removal is required. Beyond conventional diuretic use, recent research explores bumetanide's potential in neurological disorders due to its modulation of GABAergic signaling. This includes experimental applications in autism spectrum disorders and neonatal seizures, though these uses remain off-label.
Safety and Storage
Proper handling of bumetanide requires attention to its potential adverse effects, including electrolyte disturbances (hypokalemia, hyponatremia), ototoxicity at high doses, and possible allergic reactions in sulfonamide-sensitive individuals. Storage should maintain the compound in its original packaging at controlled room temperature (20-25°C), protected from light and moisture. Bulk pharmaceutical quantities require proper labeling and secure storage to prevent unauthorized access, with special consideration given to its prescription-only status.
B2B Procurement Guide
Pharmaceutical manufacturers sourcing bumetanide should verify the supplier's GMP compliance and certificate of analysis confirming purity (typically ≥98%). Batch-to-batch consistency is critical for formulation quality. Procurement professionals should establish long-term relationships with accredited suppliers capable of providing full regulatory documentation. Current market prices fluctuate based on purity grade and order volume, with contract manufacturing arrangements often offering cost advantages for large-scale production needs.